You’ll find the latest information about procedure codes and Blue Cross Blue Shield of Michigan billing guidelines in the following chart. The codes that have a change to a billing guideline or added a new payable group will appear under Updates to Payable Procedures.
|UPDATES TO PAYABLE PROCEDURES|
Because there is no code for this service, the above procedure should be reported with this not otherwise classified code.
|Basic Benefit Policy
The safety and effectiveness of CYP450 genotyping for CYP2C19 *2 and *3 alleles have been established. It may be considered a useful diagnostic option for selected patients who meet specific patient selection criteria.
Effective Nov. 1, 2011, genetic testing for Cytochrome P450 Polymorphisms is payable when used for patients undergoing treatment with clopidogrel (PlavixÆ) in order to identify those who are poor metabolizers of the drug, for GM hourly and salaried employees.